| × |  | PDF: Update on Drugs & Devices: July-August 2025 | $1.99 | | $1.99 |
| × | | PDF: Nanodermatology | $1.99 | | $1.99 |
| × | | PDF: Lebrikizumab for Moderate-to-Severe Atopic Dermatitis | $1.99 | | $1.99 |
| × | | Purchase whole issue (PDF): July-August 2025 | $2.79 | | $2.79 |
| × | | PDF: Update on Drugs & Devices: May-June 2025 | $1.99 | | $1.99 |
| × | | PDF: A Novel Fixed Dose Triple Combination Therapy (IDP-126) for Moderate to Severe Acne | $1.99 | | $1.99 |
| × | | PDF: Use of Nemolizumab in the Treatment of Prurigo Nodularis and Atopic Dermatitis | $1.99 | | $1.99 |
| × | | Purchase whole issue (PDF): May-June 2025 | $2.79 | | $2.79 |
| × | | PDF: Update on Drugs & Devices: March-April 2025 | $1.99 | | $1.99 |
| × | | PDF: Targeting IL-23 in Psoriatic Arthritis: A Review of Guselkumab’s Efficacy and Utilization | $1.99 | | $1.99 |
| × | | Purchase whole issue (PDF): Mar-Apr 2025 | $2.79 | | $2.79 |
| × | | PDF: Update on Drugs & Devices: January-February 2025 | $1.99 | | $1.99 |
| × | | PDF: An Update on the Clinical Management of Cutaneous Leishmaniasis | $1.99 | | $1.99 |
| × | | PDF: Pediatric Hidradenitis Suppurativa: An Overview | $1.99 | | $1.99 |
| × | | Purchase whole issue (PDF): Jan-Feb 2025 | $2.79 | | $2.79 |
| × | | PDF: Update on Drugs & Devices: November-December 2024 | $1.99 | | $1.99 |
| × | | PDF: A Multimodal Approach to Acne-Induced Post-Inflammatory Hyperpigmentation: Trifarotene as a Long-Term Intervention | $1.99 | | $1.99 |
| × | | PDF: A Review of the Role and Treatment of Biofilms in Skin Disorders | $1.99 | | $1.99 |
| × | | Purchase whole issue (PDF): Nov-Dec 2024 | $2.79 | | $2.79 |
| × | | PDF: Inhaled Analgesia in Dermatologic Settings: A Comprehensive Overview of Methoxyflurane | $1.99 | | $1.99 |
| × | | PDF: Enhancing Bioavailability: Advances in Oral Isotretinoin Formulations | $1.99 | | $1.99 |
| × | | PDF: Update on Drugs & Devices: September-October 2024 | $1.99 | | $1.99 |
| × | | Purchase whole issue (PDF): Sep-Oct 2024 | $2.79 | | $2.79 |
| × | | PDF: Update on Drugs & Devices: July – August 2024 | $1.99 | | $1.99 |
| × | | PDF: An Overview on the Management of Atrophic Acne Scars: The Role of Trifarotene as an Adjunct | $1.99 | | $1.99 |
| × | | Purchase whole issue (PDF): Jul-Aug 2024 | $2.79 | | $2.79 |
| × | | PDF: Update on Drugs & Devices: May – June 2024 | $1.99 | | $1.99 |
| × | | PDF: Long-Term Efficacy of Tildrakizumab in the Treatment of Psoriasis | $1.99 | | $1.99 |
| × | | PDF: A Review of the Use of Intravenous Immunoglobulin Therapy in Dermatology | $1.99 | | $1.99 |
| × | | Purchase whole issue (PDF): May-Jun 2024 | $2.79 | | $2.79 |
| × | | PDF: Update on Drugs & Devices: March – April 2024 | $1.99 | | $1.99 |
| × | | PDF: Overview of Dermatological Manifestations Associated with the COVID-19 Infection | $1.99 | | $1.99 |
| × | | PDF: An Update on Current Clinical Management and Emerging Treatments in Hidradenitis Suppurativa | $1.99 | | $1.99 |
| × | | Purchase whole issue (PDF): Mar-Apr 2024 | $2.79 | | $2.79 |
| × | | PDF: 1726 nm Lasers for the Treatment of Acne Vulgaris | $1.99 | | $1.99 |
| × | | PDF: Update on Drugs & Devices: January – February 2024 | $1.99 | | $1.99 |
| × | | Purchase whole issue (PDF): Jan-Feb 2024 | $1.99 | | $1.99 |
| × | | PDF: Risankizumab in Adults with Psoriatic Arthritis | $1.99 | | $1.99 |
| × | | PDF: Update on Drugs & Devices: November-December 2023 | $1.99 | | $1.99 |
| × | | Purchase whole issue (PDF): Nov-DEC 2023 | $2.79 | | $2.79 |
| × | | PDF: Topical Roflumilast for Plaque Psoriasis | $1.99 | | $1.99 |
| × | | PDF: A Practical Guide to Advanced Topical Drug Delivery Systems in Dermatology | $1.99 | | $1.99 |
| × | | Purchase whole issue (PDF): Sept-Oct 2023 | $2.79 | | $2.79 |
| × | | PDF: DaxibotulinumtoxinA-lanm (Daxxify™): A Comprehensive Overview | $1.99 | | $1.99 |
| × | | PDF: Prevention of Shingles in Dermatology Patients on Systemic Medications | $1.99 | | $1.99 |
| × | | Purchase whole issue (PDF): July-August 2023 | $2.79 | | $2.79 |
| × | | PDF: The Evolving Story of JAK Inhibitors for Treating Alopecia Areata: A Review of Current Progress and Future Directions | $1.99 | | $1.99 |
| × | | PDF: Utilization of Topical Ruxolitinib in Dermatology: A Review | $1.99 | | $1.99 |
| × | | Purchase whole issue (PDF): May-June 2023 | $2.79 | | $2.79 |
| × | | PDF: Chlormethine Gel for the Treatment of Mycosis Fungoides (Cutaneous T-cell Lymphoma) in Canada | $1.99 | | $1.99 |
| × | | PDF: Update on Drugs & Devices: March – April 2023 | $1.99 | | $1.99 |
| × | | Purchase whole issue (PDF): Mar-Apr 2023 | $2.79 | | $2.79 |
| × | | PDF: Tralokinumab for Moderate-to-Severe Atopic Dermatitis in Adults | $1.99 | | $1.99 |
| × | | PDF: Antibiotic Resistance in Dermatology Part 1: Mechanisms of Resistance | $1.99 | | $1.99 |
| × | | PDF: Update on Drugs & Devices: January – February 2023 | $1.99 | | $1.99 |
| × | | Purchase whole issue (PDF): Jan-Feb 2023 | $2.79 | | $2.79 |
| × | | PDF: Selective TYK2 Inhibition in the Treatment of Moderate to Severe Chronic Plaque Psoriasis | $1.99 | | $1.99 |
| × | | PDF: Acne Scars: An Update on Management | $1.99 | | $1.99 |
| × | | PDF: Update on Drugs & Devices: November – December 2022 | $1.99 | | $1.99 |
| × | | Purchase whole issue (PDF): Nov-Dec 2022 | $2.79 | | $2.79 |
| × | | PDF: Toxic Epidermal Necrolysis: A Review of Past and Present Therapeutic Approaches | $1.99 | | $1.99 |
| × | | Purchase whole issue (PDF): Sept-Oct 2022 | $2.79 | | $2.79 |
| × | | PDF: Update on Drugs & Devices: July-August, 2022 | $1.99 | | $1.99 |
| × | | PDF: Tazarotene Lotion 0.045% for the Treatment of Acne | $1.99 | | $1.99 |
| × | | Purchase whole issue (PDF): July 2022 | $2.79 | | $2.79 |
| × | | PDF: Sarecycline: A Narrow-Spectrum Antibiotic | $1.99 | | $1.99 |
| × | | PDF: Update on Drugs & Devices: May-June 2022 | $1.99 | | $1.99 |
| × | | Purchase whole issue (PDF): May-June 2022 | $2.79 | | $2.79 |
| × | | PDF: Plerixafor on a WHIM – Promise or Fantasy of a New CXCR4 Inhibitor for This Rare, but Important Syndrome? | $1.99 | | $1.99 |
| × | | PDF: Transition of Topical Therapy Formulation in Psoriasis: Insights from a Canadian Practice Reflective | $1.99 | | $1.99 |
| × | | PDF: Update on Drugs & Devices: March-April 2022 | $1.99 | | $1.99 |
| × | | Purchase whole issue (PDF): March-April 2022 | $2.79 | | $2.79 |
| × | | PDF: Janus Kinase and Tyrosine Kinase Inhibitors in Dermatology: A Review | $1.99 | | $1.99 |
| × | | PDF: Update on Drugs & Devices: January-February 2022 | $1.99 | | $1.99 |
| × | | PDF: 2021 Index for Skin Therapy Letter | $1.99 | | $1.99 |
| × | | PDF: Labeling Laws for Personal Care Products: Potential Pitfalls for The Consumer | $1.99 | | $1.99 |
| × | | PDF: Update on Drugs & Devices: September – October 2021 | $1.99 | | $1.99 |
| × | | Purchase whole issue (PDF): September-October 2021 | $2.79 | | $2.79 |
| × | | PDF: Moisturizers and Cleansers in the Management of Skin Conditions Caused by Personal Protective Equipment and Frequent Handwashing | $1.99 | | $1.99 |
| × | | PDF: Update on Drugs & Devices: July – August 2021 | $1.99 | | $1.99 |
| × | | PDF: Bimekizumab for Moderate-to-Severe Plaque Psoriasis | $1.99 | | $1.99 |
| × | | PDF: Prurigo Nodularis: Review and Emerging Treatments | $1.99 | | $1.99 |
| × | | PDF: Update on Drugs & Devices: May-June 2021 | $1.99 | | $1.99 |
| × | | Purchase whole issue (PDF): Nov-Dec 2017 | $2.79 | | $8.37 |
| × | | Purchase whole issue (PDF): Sep-Oct 2016 | $2.79 | | $2.79 |
| × | | Purchase whole issue (PDF): Jul-Aug 2017 | $2.79 | | $5.58 |
| × | | Purchase whole issue (PDF): May-Jun 2016 | $2.79 | | $2.79 |
| × | | Purchase whole issue (PDF): Nov-Dec 2016 | $2.79 | | $2.79 |
| × | | Purchase whole issue (PDF): Jul-Aug 2014 | $2.79 | | $2.79 |
| × | | Purchase whole issue (PDF): Mar-Apr 2015 | $2.79 | | $2.79 |
| × | | Purchase whole issue (PDF): Nov-Dec 2014 | $2.79 | | $2.79 |
| × | | Purchase whole issue (PDF): Jan-Feb 2015 | $2.79 | | $2.79 |
| × | | Purchase whole issue (PDF): May-Jun 2015 | $2.79 | | $2.79 |
| × | | Purchase whole issue (PDF): Jan-Feb 2017 | $2.79 | | $2.79 |
| × | | Purchase whole issue (PDF): Mar-Apr 2014 | $2.79 | | $2.79 |
| × | | Purchase whole issue (PDF): Mar-Apr 2017 | $2.79 | | $2.79 |
| × | | Purchase whole issue (PDF): May-Jun 2014 | $2.79 | | $2.79 |
| × | | Purchase whole issue (PDF): Mar-Apr 2016 | $2.79 | | $2.79 |
| × | | Purchase whole issue (PDF): Jul-Aug 2015 | $2.79 | | $2.79 |
| × | | Purchase whole issue (PDF): Jan-Feb 2014 | $2.79 | | $2.79 |
| × | | Purchase whole issue (PDF): May-Jun 2017 | $2.79 | | $2.79 |
| × | | Purchase whole issue (PDF): Jul-Aug 2016 | $2.79 | | $2.79 |
| × | | Purchase whole issue (PDF): Sep-Oct 2014 | $2.79 | | $2.79 |
| × | | Purchase whole issue (PDF): Nov-Dec 2015 | $2.79 | | $2.79 |
| × | | Purchase whole issue (PDF): Sep-Oct 2017 | $2.79 | | $2.79 |
| × | | Purchase whole issue (PDF): Sep-Oct 2015 | $2.79 | | $2.79 |
| × | | PDF: Crisaborole 2% Ointment (Eucrisa) for Atopic Dermatitis | $1.99 | | $1.99 |
| × | | PDF: Alitretinoin: An Update of Real-World Evidence in The Management of Chronic Hand Dermatitis | $1.99 | | $1.99 |
| × | | PDF: Dupilumab for Moderate-to-Severe Atopic Dermatitis | $1.99 | | $1.99 |
| × | | PDF: Update on Drugs & Devices: May – June 2020 | $1.99 | | $1.99 |
| × | | Purchase whole issue (PDF): May-June 2021 | $2.79 | | $2.79 |
| × | | PDF: Skin Treatments Introduced in 2020 | $1.99 | | $1.99 |
| × | | PDF: Update on Drugs & Devices: March-April 2021 | $1.99 | | $1.99 |
| × | | PDF: Long-term Efficacy and Safety of Once-daily Efinaconazole 10% Topical Solution (Jublia) for Dermatophyte Toenail Onychomycosis: An Interim Analysis | $1.99 | | $1.99 |
| × | | PDF: Update on Drugs & Devices: January-February 2021 | $1.99 | | $1.99 |
| × | | Purchase whole issue (PDF): January-February 2021 | $2.79 | | $2.79 |
| × | | PDF: Nicotinamide: An Update and Review of Safety & Differences from Niacin | $1.99 | | $1.99 |
| × | | PDF: Dermatologic Applications and Safety Considerations of Janus Kinase Inhibitors | $1.99 | | $1.99 |
| × | | Purchase whole issue (PDF): September-October 2020 | $2.79 | | $2.79 |
| × | | Purchase whole issue (PDF): May-June 2020 | $2.79 | | $2.79 |
| × | | PDF: A Novel Topical Retinoid for Acne: Trifarotene 50 μg/g Cream | $1.99 | | $1.99 |
| × | | PDF: An Anti-Wrinkle Diet: Nutritional Strategies to Combat Oxidation, Inflammation and Glycation | $1.99 | | $1.99 |
| × | | Purchase whole issue (PDF): Mar-Apr 2020 | $2.79 | | $2.79 |
| × | | Volume 24 (ZIP file). 6 PDF Issues, 20 Articles. | $7.99 | | $7.99 |
| × | | PDF: Update on Drugs & Devices: November – December 2019 | $1.99 | | $1.99 |
| × | | Purchase whole issue (PDF): Nov-Dec 2019 | $2.79 | | $2.79 |
| × | | PDF: Update on Drugs & Devices: September – October 2019 | $1.99 | | $1.99 |
| × | | Purchase whole issue (PDF): November 2020 | $2.79 | | $2.79 |
| × | | PDF: A Closer Look at the Data Regarding Suicidal Ideation and Behavior in Psoriasis Patients: The Case of Brodalumab | $1.99 | | $1.99 |
| × | | PDF: Shingrix for Herpes Zoster: A Review | $1.99 | | $1.99 |
| × | | PDF: Update on Drugs & Devices: July – August 2019 | $1.99 | | $1.99 |
| × | | PDF: Update on the Management of Vitiligo | $1.99 | | $1.99 |
| × | | PDF: Topical Diacerein Cream for Epidermolysis Bullosa Simplex: A Review | $1.99 | | $1.99 |
| × | | PDF: Update on Drugs & Devices: May – June 2019 | $1.99 | | $1.99 |
| × | | Purchase whole issue (PDF): May-Jun 2019 | $2.79 | | $2.79 |
| × | | PDF: Glycopyrronium Tosylate (Qbrexza) for Hyperhidrosis | $1.99 | | $1.99 |
| × | | PDF: Skin Treatments Introduced in 2018 | $1.99 | | $1.99 |
| × | | PDF: Update on Drugs & Devices: March – April 2019 | $1.99 | | $1.99 |
| × | | PDF: The Treatment of Primary Focal Hyperhidrosis | $1.99 | | $1.99 |
| × | | PDF: Update on Immunotherapeutics in the Management of Metastatic Melanoma | $1.99 | | $1.99 |
| × | | PDF: Index for STL Volume 23 (2018) | $1.99 | | $1.99 |
| × | | Purchase whole issue (PDF): Jan-Feb 2019 | $2.79 | | $2.79 |
| × | | PDF: Afamelanotide in the Treatment of Dermatologic Disease | $1.99 | | $1.99 |
| × | | PDF: Update on Drugs & Devices: November – December 2018 | $1.99 | | $1.99 |
| × | | PDF: Non-Invasive Gene Expression Testing to Rule Out Melanoma | $1.99 | | $1.99 |
| × | | PDF: Chronic Pruritus: A Review of Neurophysiology and Associated Immune Neuromodulatory Treatments | $1.99 | | $1.99 |
| × | | Purchase whole issue (PDF): August 2018 | $2.79 | | $2.79 |
| × | | PDF: The Evolution of Topical Formulations in Psoriasis | $1.99 | | $1.99 |
| × | | PDF: Update on Drugs & Devices: July – August 2018 | $1.99 | | $1.99 |
| × | | PDF: Janus Kinase Inhibitors: A Review of Their Emerging Applications in Dermatology | $1.99 | | $1.99 |
| × | | Purchase whole issue (PDF): May-Jun 2018 | $2.79 | | $2.79 |
| × | | Purchase whole issue (PDF): March 2018 | $2.79 | | $2.79 |
| × | | PDF: A Review of Fabry Disease | $1.99 | | $1.99 |
| × | | PDF: Skin Treatments Introduced in 2017 | $1.99 | | $1.99 |
| × | | Purchase whole issue (PDF): Mar-Apr 2018 | $2.79 | | $2.79 |
| × | | PDF: New Treatments for Hereditary Angioedema | $1.99 | | $1.99 |
| × | | Purchase whole issue (PDF): Jan-Feb 2018 | $2.79 | | $2.79 |
| × | | Purchase whole issue (PDF): December 2017 | $2.79 | | $2.79 |
| × | | PDF: Real-World Efficacy of Azelaic Acid 15% Gel for the Reduction of Inflammatory Lesions of Rosacea | $1.99 | | $1.99 |
| × | | PDF: Vitamin B Derivative (Nicotinamide) Appears to Reduce Skin Cancer Risk | $1.99 | | $1.99 |
| × | | Purchase whole issue (PDF): September 2017 | $2.79 | | $2.79 |
| × | | PDF: Epidermal Growth Factor Receptor Inhibitors: Cutaneous Side Effects and Their Management | $1.99 | | $1.99 |
|
